PUTNAM INVESTMENTS LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$284,332
-96.8%
34,011
-85.3%
0.00%
-100.0%
Q2 2021$8,972,000
+50.3%
231,293
+86.7%
0.01%
+40.0%
Q1 2021$5,971,000
-7.4%
123,8930.0%0.01%
-9.1%
Q4 2020$6,445,000
+155.6%
123,893
+31.5%
0.01%
+120.0%
Q3 2020$2,522,000
+131.4%
94,246
+13.7%
0.01%
+400.0%
Q2 2018$1,090,000
-17.0%
82,888
-10.4%
0.00%
-66.7%
Q1 2018$1,314,00092,5430.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders